JPS6058911B2 - Isonicotinic acid hydrazide derivative and method for producing the same - Google Patents

Isonicotinic acid hydrazide derivative and method for producing the same

Info

Publication number
JPS6058911B2
JPS6058911B2 JP6088579A JP6088579A JPS6058911B2 JP S6058911 B2 JPS6058911 B2 JP S6058911B2 JP 6088579 A JP6088579 A JP 6088579A JP 6088579 A JP6088579 A JP 6088579A JP S6058911 B2 JPS6058911 B2 JP S6058911B2
Authority
JP
Japan
Prior art keywords
group
acid hydrazide
isonicotinic acid
substituted
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6088579A
Other languages
Japanese (ja)
Other versions
JPS55151561A (en
Inventor
茂 山辺
純一 山下
貞夫 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP6088579A priority Critical patent/JPS6058911B2/en
Publication of JPS55151561A publication Critical patent/JPS55151561A/en
Publication of JPS6058911B2 publication Critical patent/JPS6058911B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は一般式 δHN:CH心 ( I ) ゜〔式中Rは水酸基で置換されもしくはされない低級ジ
アルキルアミノ基、脂環状アミノ基、モルホリノ基また
は低級アルキル基で置換されもしくはされないピペラジ
ノ基を表わす〕で示される新規イソニコチン酸ヒドラジ
ド誘導体およびその製造方法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula δHN:CH center (I) [wherein R is substituted with a lower dialkylamino group, an alicyclic amino group, a morpholino group, or a lower alkyl group, which may or may not be substituted with a hydroxyl group. The present invention relates to a novel isonicotinic acid hydrazide derivative represented by the following formula (representing a piperazino group) and a method for producing the same.

本発明の新規なイソニコチン酸ヒドラジド誘導体は病原
菌特に結核菌に対して強い抗菌作用を有し、結核の治療
に有用である。
The novel isonicotinic acid hydrazide derivatives of the present invention have strong antibacterial activity against pathogenic bacteria, particularly Mycobacterium tuberculosis, and are useful for the treatment of tuberculosis.

本発明の新規化合物(1)は以下に示す方法によつて製
造することができる。
The novel compound (1) of the present invention can be produced by the method shown below.

〔ただし式中Rは先に定義したものと同一の意義を有し
、xはハロゲンを示す〕すなわち本発明の新規化合物の
製法によればo−ホルミルベンゼンスルホニルハライド
(■)と、水酸基で置換されもしくはされない低級ジア
ルキルアミン、脂環状アミン、モルホリンおよび低級ア
ルキル基で置換されもしくはされないピペラジンの群か
ら第2級アミンと反応させて化合物(■)を得、次いで
化合物(■)をイソニコチン酸ヒドラジドと反応させて
新規イソニコチン酸ヒドラジド誘導体(1)を得ること
ができる。
[However, in the formula, R has the same meaning as defined above, and x represents a halogen] That is, according to the method for producing the new compound of the present invention, o-formylbenzenesulfonyl halide (■) and a hydroxyl group are substituted. Compound (■) is obtained by reacting with a secondary amine from the group of lower dialkylamines, alicyclic amines, morpholine, and piperazines substituted or unsubstituted with lower alkyl groups, and then compound (■) is converted into isonicotinic acid hydrazide. The novel isonicotinic acid hydrazide derivative (1) can be obtained by reacting with

本発明化合物の製造方法に於いて出発物質として用いら
れるo−ホルミルベンゼンスルホニルハライド(■)は
公知の化合物であり、例えばカナデイアン ジャーナル
オブ ケミストリー 第4晴、第943頁、1971
年等に記載されている。式(■)のXとしてはF,.C
l、Br及びIを挙げることができる。また本発明の第
2級アミンとしては次の如き化.合物を用いることがで
きる。
The o-formylbenzenesulfonyl halide (■) used as a starting material in the method for producing the compound of the present invention is a known compound, for example, Canadian Journal of Chemistry, No. 4, p. 943, 1971.
It is listed in the year etc. As X in formula (■), F, . C
1, Br and I may be mentioned. Further, the secondary amines of the present invention include the following compounds. A compound can be used.

(1)水酸基で置換されもしくはされない低級ジアルキ
ルアミン、ここで低級アルキル基としては炭素数1〜8
のアルキル基を挙げることができる。上記アミンの具体
例としてはジメチルアミン、ジエチルアミン、ジプロ・
ビルアミン、ジブチルアミン、ジオクチルアミン、ジエ
タノールアミン、ジプロパノールアミン等を挙げること
ができる。(2)脂環状アミン、具体的にはピロリジン
、ピペリジン等を挙げることができる。(3)モルホリ
ン。(4)低級アルキル基で置換されもしくはされない
ピペラジン、ここで低級アルキル基としては炭素数1〜
8のアルキル基を挙ノげることができる。上記ピペラジ
ン類の具体例としてはピペラジン、N−メチルピペラジ
ン、N−エチルピペラジン、N−プロピルピペラジン、
N一ブチルピペラジン、N−ヘキシルピペラジン、N−
オクチルピペラジン等を挙げることができる。0−ホル
ミルベンゼンスルホニルハライド(■)と第2級アミン
類との反応はo−ホルミルベンゼンスルホニルハライド
(■)1モルに対して1モル以上の第2級アミン類を用
いる。
(1) Lower dialkylamine substituted or unsubstituted with a hydroxyl group, where the lower alkyl group has 1 to 8 carbon atoms.
The following alkyl groups can be mentioned. Specific examples of the above amines include dimethylamine, diethylamine, dipro-
Examples include biruamine, dibutylamine, dioctylamine, diethanolamine, and dipropanolamine. (2) Alicyclic amines, specifically pyrrolidine, piperidine and the like. (3) Morpholine. (4) Piperazine substituted or unsubstituted with a lower alkyl group, where the lower alkyl group has 1 to 1 carbon atoms.
8 alkyl groups may be mentioned. Specific examples of the piperazines mentioned above include piperazine, N-methylpiperazine, N-ethylpiperazine, N-propylpiperazine,
N-butylpiperazine, N-hexylpiperazine, N-
Octylpiperazine and the like can be mentioned. For the reaction between 0-formylbenzenesulfonyl halide (■) and secondary amines, 1 mol or more of the secondary amine is used per 1 mol of o-formylbenzenesulfonyl halide (■).

反応は通常約−10〜30℃の温度で行うが、好ましく
は約一10〜5℃の条件において行なう。反応溶媒とし
ては本反応に関与しないものであれば特に限定されない
が、クロロホルム、ジクロロメタン、ジクロロエタン、
ニトロメタン、ジオキサン等の非プロトン性極性溶媒を
使用するのが好ましい。反応は通常脱ノ和ゲン化水素剤
の存在下に行うが、原料の第2級アミン類を過剰に加え
ることで代用することもできる。使用する脱ハロゲン化
水素剤としてはトリエチルアミン、トリメチルアミン、
ピリジン、ピコリン等の第3級アミンを用い、o−ホル
ミルベンゼンスルホニルハライド(■)1モルに対して
通常は1モル以上を使用するが、ピリジン、ピコリン等
を溶媒として使用することもできる。反応時間は通常約
1〜1C@間である。反応中間体(■)とイソニコチン
酸ヒドラジドとの反応は通常中間体(■)を単離した後
行なうが、単離せずに行なうこともできる。
The reaction is usually carried out at a temperature of about -10 to 30°C, preferably about -10 to 5°C. The reaction solvent is not particularly limited as long as it does not participate in this reaction, but examples include chloroform, dichloromethane, dichloroethane,
Preferably, aprotic polar solvents such as nitromethane, dioxane, etc. are used. The reaction is usually carried out in the presence of a de-hydrogenating agent, but it can be substituted by adding an excess of secondary amines as raw materials. The dehydrohalogenating agents used include triethylamine, trimethylamine,
A tertiary amine such as pyridine or picoline is used, and usually 1 mole or more is used per mole of o-formylbenzenesulfonyl halide (■), but pyridine, picoline, etc. can also be used as a solvent. The reaction time is usually between about 1 and 1 C@. The reaction between the reaction intermediate (■) and isonicotinic acid hydrazide is usually carried out after isolation of the intermediate (■), but it can also be carried out without isolation.

中間体を単離せずに反応を続けて行なう時には、イソニ
コチン酸ヒドラジドの溶解性を考慮し、メタノール、エ
タノール等のプロトン性極性溶媒を適宜加える。反応は
通常室温でも十分に進行するが、加温することにより反
応時間を短縮することができる。溶媒は反応に関与しな
いものであれば特に限一定されないが、たとえば水ある
いはメタノール、エタノールなどのアルコール類、ジエ
チルエーテル、ジオキサンなどのエーテル類、クロロホ
ルム、ジクロロメタン、ジクロロエタンなどのハロゲン
化炭化水素類またはピリジン、ピコリンなどのアミン類
があげられる。通常メタノール、エタノール等のプロト
ン性極性溶媒を使用することが好ましい。中間体(■)
1モルに対してイソニコチン酸ヒドラジド約1〜2.5
モルを用いて反応を行うのが好ましい。本発明化合物は
従来公知の慣用手段、例えば、再結晶、カラムクロマト
グラフィー等により容易に精製される。
When the reaction is continued without isolating the intermediate, a protic polar solvent such as methanol or ethanol is appropriately added in consideration of the solubility of isonicotinic acid hydrazide. Although the reaction usually proceeds satisfactorily at room temperature, the reaction time can be shortened by heating. The solvent is not particularly limited as long as it does not participate in the reaction, but examples include water, alcohols such as methanol and ethanol, ethers such as diethyl ether and dioxane, halogenated hydrocarbons such as chloroform, dichloromethane and dichloroethane, or pyridine. , and amines such as picoline. Usually, it is preferable to use a protic polar solvent such as methanol or ethanol. Intermediate (■)
About 1-2.5 isonicotinic acid hydrazide per mole
Preferably, the reaction is carried out using moles. The compound of the present invention can be easily purified by conventionally known methods such as recrystallization and column chromatography.

このようにして得られるイソニコチン酸ヒドラジド誘導
体(1)は抗結核菌作用を有し、抗結核剤として有用な
化合物である。本発明の新規化合物の1つである2−ジ
メチルスルフアモイルベンザルイソニコチニルヒドラゾ
ンのミコバクテリウムツベルクローシスH37R,株に
対する試験管内最小発育阻止濃度は、デユボスアルブミ
ン液体培地を用いて測定して結果(37℃で3週間培養
後)は0.04μGlmtであり、これは対照薬とした
イソニコチン酸ヒドラジドの値0.05py1mLを上
廻る強い抗菌性であり、一方マウスを用いた急性毒性試
験の結果では、2−ジメチルスルフアモイルベンザルイ
ソニコチニルヒドララゾンのLD5O値は1007m9
1k9であり、これは対照としたイソニコチン酸ヒドラ
ジドのLD5O値251Tn91k9の約114の低毒
性であつた。以上のように本発明の新規イソニコチン酸
ヒドラジド誘導体は従来のイソニコチン酸ヒドラジドに
比し著しく低毒性であると同時にその抗菌活性において
もより優れており、新規有用な化合物である。
The isonicotinic acid hydrazide derivative (1) thus obtained has an antituberculous action and is a compound useful as an antituberculous agent. The in vitro minimum inhibitory concentration of 2-dimethylsulfamoylbenzalisonicotinyl hydrazone, one of the novel compounds of the present invention, against Mycobacterium tuberculosis H37R strain was determined using a dejuboalbumin liquid medium. The result (after 3 weeks of incubation at 37°C) was 0.04μGlmt, which is a strong antibacterial agent that exceeds the value of isonicotinic acid hydrazide as a control drug, 0.05py1mL, while acute toxicity using mice According to the test results, the LD5O value of 2-dimethylsulfamoylbenzalisonicotinylhydralazone is 1007m9
1k9, which had a low toxicity of about 114 compared to the LD5O value of isonicotinic acid hydrazide, which was used as a control, of 251Tn91k9. As described above, the novel isonicotinic acid hydrazide derivative of the present invention has significantly lower toxicity and superior antibacterial activity than conventional isonicotinic acid hydrazide, and is a new and useful compound.

以下に実施例を挙げて本発明を具体的に説明する。The present invention will be specifically explained below with reference to Examples.

実施例1 0−ホルミルベンゼンスルホニルクロライド6f1(0
.03モル)をジクロロメタン60m1に溶解し、氷水
冷却下トリエチルアミン4.1(0.03モル)を滴下
する。
Example 1 0-formylbenzenesulfonyl chloride 6f1 (0
.. 03 mol) was dissolved in 60 ml of dichloromethane, and 4.1 (0.03 mol) of triethylamine was added dropwise while cooling with ice water.

次いでメチルピペラジン3y(0.03モル)を加えて
1時間攪拌した後反応液を減圧濃縮する。残渣クロロホ
ルム−エタノール混液に溶解し、シリカゲルカラムを通
し溶出液を分取して減圧濃縮する。残渣5.49(0.
02モル)をエタノール30m1に溶解し、イソニコチ
ン酸ヒドラジド2.7(イ).02モル)を加えて室温
で3時間攪拌する。反応液を減圧濃縮し、残渣を酢酸エ
チルエステルに溶解した後エーテルを加え析出する沈澱
をp取する。この沈澱を酢酸エチルエステルーエーテル
より再結晶して2−(4−メチルー1−ピペラジニルス
ルホニル)ベンザルイソニコチニルヒドラゾンの結晶5
.2y(収率44.8%)を得る。融点176.5〜1
785C元素分析Cl8H2lN,O3Sとして 計算値(%):C55.8O;H5.46;Nl8.O
8実測値(%):C55.87;H5.54:Nl7.
93実施例2 0−ホルミルベンゼンスルホニルクロライド10.2y
(0.05モル)をジクロロメタン90m1に溶解し、
氷水冷却下トリエチルアミン7m1(イ).05)をk
滴下する。
Next, methylpiperazine 3y (0.03 mol) was added, and after stirring for 1 hour, the reaction solution was concentrated under reduced pressure. The residue is dissolved in a chloroform-ethanol mixture, passed through a silica gel column, and the eluate is fractionated and concentrated under reduced pressure. Residue 5.49 (0.
02 mol) of isonicotinic acid hydrazide was dissolved in 30 ml of ethanol. 02 mol) and stirred at room temperature for 3 hours. The reaction solution was concentrated under reduced pressure, the residue was dissolved in ethyl acetate, ether was added, and the precipitate was collected. This precipitate was recrystallized from ethyl acetate-ether to obtain crystals of 2-(4-methyl-1-piperazinylsulfonyl)benzalisonicotinyl hydrazone 5.
.. 2y (yield 44.8%) is obtained. Melting point 176.5~1
785C elemental analysis Cl8H2lN, Calculated value (%) as O3S: C55.8O; H5.46; Nl8. O
8 Actual value (%): C55.87; H5.54: Nl7.
93 Example 2 0-formylbenzenesulfonyl chloride 10.2y
(0.05 mol) was dissolved in 90 ml of dichloromethane,
7 ml of triethylamine under cooling with ice water (a). 05) to k
Drip.

次いで溶液中に過剰のジメチルアミンガスを導入し、3
時間攪拌した後反応液を減圧濃縮する。残渣をクロロホ
ルム−エタノール(20:1)混液に溶解し、シリカゲ
ルカラムを通し溶出液を分7取して減圧濃縮する。
Then, excess dimethylamine gas is introduced into the solution, and 3
After stirring for an hour, the reaction solution was concentrated under reduced pressure. The residue was dissolved in a chloroform-ethanol (20:1) mixture, passed through a silica gel column, and the eluate was collected in 7 fractions and concentrated under reduced pressure.

残渣9y(0.042モル)をエタノール100m1に
溶解し、イソニコチン酸ヒドラジド5.8y(0.04
3モル)を加えて室温で1濁間攪拌する。析出する沈澱
を沖取してこれをクロロホルム−エタノールにより再結
晶し2−ジメチルスルフアモイルベンザルイソニコチニ
ルヒドラジン結晶11.69(収率69.8%)を得る
。融点214〜216.5.C元素分析Cl5Hl6N
4O3Sとして 計算値(%):C54.2O;H4.85;N16.8
6実測値(%):C54.35;H4.89;Nl6.
49実施例3 0−ホルミルベンゼンスルホニルクロライド4.3y(
0.02モル)をジクロルメタン4077!lに溶解し
、氷水冷却下トリエチルアミン377!L(0.02モ
ル)を滴下する。
The residue 9y (0.042 mol) was dissolved in 100 ml of ethanol, and 5.8y (0.04 mol) of isonicotinic acid hydrazide was dissolved in 100 ml of ethanol.
3 mol) and stirred at room temperature for 1 turbidity. The resulting precipitate was taken off the coast and recrystallized from chloroform-ethanol to obtain 11.69 crystals of 2-dimethylsulfamoylbenzalisonicotinylhydrazine (yield: 69.8%). Melting point 214-216.5. C elemental analysis Cl5Hl6N
Calculated value (%) as 4O3S: C54.2O; H4.85; N16.8
6 Actual value (%): C54.35; H4.89; Nl6.
49 Example 3 0-formylbenzenesulfonyl chloride 4.3y (
0.02 mol) of dichloromethane 4077! Dissolve triethylamine in 377 liters of water and cool with ice water. Add L (0.02 mol) dropwise.

次いでジイソプロピルアミン2.1y(0.02モル)
を加えて室温で8時間攪拌した、後減圧濃縮する。残渣
をクロロホルムに溶解しシリカゲルカラムを通し溶出液
を分取し減圧濃縮する。
Then diisopropylamine 2.1y (0.02 mol)
was added and stirred at room temperature for 8 hours, then concentrated under reduced pressure. Dissolve the residue in chloroform, pass through a silica gel column, collect the eluate, and concentrate under reduced pressure.

残渣29をエタノール32m1、クロロホルム9.6T
ntの混液に溶解しイソニコチン酸ヒドラジド1.05
y(0.0076モル)を加えて室温で8時間攪拌する
Residue 29 was mixed with 32 ml of ethanol and 9.6 T of chloroform.
isonicotinic acid hydrazide dissolved in a mixture of nt.
y (0.0076 mol) and stirred at room temperature for 8 hours.

反応液を減圧濃縮し残渣をエタノールから再結晶して2
−ジイソプロピルスルフアモイルベンザルイソニコチニ
ルヒドラゾンの結晶2.4f(収率30%)を得る。融
点183〜186℃元素分析Cl9H24N4O3Sと
して 計算値(%):C58.74;H6.23;Nl4.4
2実測値(%):C58.77;H6.4l;Nl4.
39実施例4 0−ホルミルベンゼンスルホニルクロライド4.3y(
0.02モル)をジクロロメタン40m1に溶解し、氷
水冷却下トリエチルアミン3m1(0.02モル)を滴
下する。
The reaction solution was concentrated under reduced pressure, and the residue was recrystallized from ethanol.
-Crystals 2.4f (yield 30%) of diisopropylsulfamoylbenzalisonicotinyl hydrazone are obtained. Melting point 183-186℃ Elemental analysis Calculated value (%) as Cl9H24N4O3S: C58.74; H6.23; Nl4.4
2 Actual value (%): C58.77; H6.4l; Nl4.
39 Example 4 0-formylbenzenesulfonyl chloride 4.3y (
0.02 mol) was dissolved in 40 ml of dichloromethane, and 3 ml (0.02 mol) of triethylamine was added dropwise while cooling with ice water.

次いでジエタノールアミン2.2y(0.02モル)を
加えて室温で8時間攪拌した後こ減圧濃縮する。残渣を
クロロホルム−エタノール(5:1)混液50m1に溶
解しシリカゲルカラムを通して溶出液を分取して減圧濃
縮する。残渣2.6をエタノール50m1に溶解しイソ
ニコチン酸ヒドラジド1.32′(0.0096モル)
を加えて室温て8時間攪拌する。
Next, 2.2y (0.02 mol) of diethanolamine was added and the mixture was stirred at room temperature for 8 hours, and then concentrated under reduced pressure. The residue was dissolved in 50 ml of a chloroform-ethanol (5:1) mixture, passed through a silica gel column, and the eluate was fractionated and concentrated under reduced pressure. Residue 2.6 was dissolved in 50 ml of ethanol and 1.32' (0.0096 mol) of isonicotinic acid hydrazide was dissolved.
and stirred at room temperature for 8 hours.

反応液を減圧濃縮し残渣をエタノールから再結晶して2
−ジエタノールスルフアモイルベンザルイソニコチニル
ヒドラゾンの結晶2.9y(収率36.9%)を得る。
融点169〜170℃元素分析Cl7H2ON4O5S
として 計算値(%):C52.O3;H5.l4;Nl4.2
8実測値(%):C52.l6;H5.37;Nl4.
l2実施例5 0−ホルミルベンゼンスルホニルクロライド4.3f(
0.02モル)をジクロロメタン40m1に溶解し、氷
水冷却下トリエチルアミン3m1(イ).02モル)を
滴下する。
The reaction solution was concentrated under reduced pressure, and the residue was recrystallized from ethanol.
-Diethanol Sulfamoyl benzalisonicotinyl hydrazone crystals 2.9y (yield 36.9%) are obtained.
Melting point 169-170℃ Elemental analysis Cl7H2ON4O5S
Calculated value (%): C52. O3; H5. l4;Nl4.2
8 Actual value (%): C52. l6; H5.37; Nl4.
l2 Example 5 0-formylbenzenesulfonyl chloride 4.3f (
0.02 mol) was dissolved in 40 ml of dichloromethane, and 3 ml of triethylamine (a) was added under cooling with ice water. 02 mol) was added dropwise.

次いてモルホリン1.85f(0.02モル)を加えて
室温で8時間攪拌した後減圧濃縮する。残渣3.7yを
エタノール74m1、クロロホルム12m1の混合溶媒
に溶解し、イソニコチン酸ヒドラジド2y(0.015
モル)を加えて室温で2時間攪拌する。
Next, 1.85 f (0.02 mol) of morpholine was added and the mixture was stirred at room temperature for 8 hours and then concentrated under reduced pressure. 3.7y of the residue was dissolved in a mixed solvent of 74ml of ethanol and 12ml of chloroform, and 2y of isonicotinic acid hydrazide (0.015ml) was dissolved in a mixed solvent of 74ml of ethanol and 12ml of chloroform.
mol) and stirred at room temperature for 2 hours.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼( I )〔式中Rは
水酸基で置換されもしくはされない低級ジアルキルアミ
ノ基、脂環状アミノ基、モルホリノ基または低級アルキ
ル基で置換されもしくはされないピペラジノ基を表わす
〕を有するイソニコチン酸ヒドラジド誘導体。 2 o−ホルミルベンゼンスルホニルハライドと、水酸
基で置換されもしくはされない低級ジアルキルアミン、
脂環状アミン、モルホリンおよび低級アルキル基で置換
されもしくはされないピペラジンの群から選ばれた第2
級アミンとを反応させて得られる反応生成物に、次いで
イソニコチン酸ヒドラジドを反応せしめることを特徴と
する一般式▲数式、化学式、表等があります▼( I )
〔式中Rは水酸基で置換されもしくはされない低級ジア
ルキルアミノ基、脂環状アミノ基、モルホリノ基または
低級アルキル基で置換されもしくはされないピペラジノ
基を表わす〕で示されるイソニコチン酸ヒドラジド誘導
体の製造方法。
[Claims] 1. General formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (I) [In the formula, R is a lower dialkylamino group, an alicyclic amino group, a morpholino group, or a lower alkyl group substituted with or without a hydroxyl group. an isonicotinic acid hydrazide derivative having a substituted or unsubstituted piperazino group. 2 o-formylbenzenesulfonyl halide and a lower dialkylamine substituted or not substituted with a hydroxyl group,
a second selected from the group of alicyclic amines, morpholine and piperazines substituted or unsubstituted with lower alkyl groups;
The general formula is characterized by the reaction of isonicotinic acid hydrazide with the reaction product obtained by reacting with a class amine ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (I)
[In the formula, R represents a lower dialkylamino group, an alicyclic amino group, a morpholino group, or a piperazino group substituted or unsubstituted with a lower alkyl group].
JP6088579A 1979-05-16 1979-05-16 Isonicotinic acid hydrazide derivative and method for producing the same Expired JPS6058911B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6088579A JPS6058911B2 (en) 1979-05-16 1979-05-16 Isonicotinic acid hydrazide derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6088579A JPS6058911B2 (en) 1979-05-16 1979-05-16 Isonicotinic acid hydrazide derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPS55151561A JPS55151561A (en) 1980-11-26
JPS6058911B2 true JPS6058911B2 (en) 1985-12-23

Family

ID=13155264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6088579A Expired JPS6058911B2 (en) 1979-05-16 1979-05-16 Isonicotinic acid hydrazide derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JPS6058911B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10338673A (en) * 1997-06-04 1998-12-22 Nippon Bayeragrochem Kk Isonicotinic acid hydrazide derivative and pest controlling agent

Also Published As

Publication number Publication date
JPS55151561A (en) 1980-11-26

Similar Documents

Publication Publication Date Title
Trepanier et al. 1, 4, 5, 6-Tetrahydro-as-triazines. I. Sulfuric Acid Catalyzed Condensation of Nitriles and Hydrazino Alcohols1
JPS6058911B2 (en) Isonicotinic acid hydrazide derivative and method for producing the same
JPH0366310B2 (en)
JPS5953261B2 (en) Method for producing 2(1H)-pyridone derivative
JPH0458468B2 (en)
US3551498A (en) Dehydrogenation of 10,11-dihydro-5h-dibenzo(a,d)cycloheptene-5-one
JPS5936627B2 (en) Production method of indazole derivatives
Franco et al. Diheterocyclic compounds from dithiocarbamates and derivatives thereof. VII. 1‐(2‐benzazolylaminophenylsulphonyl)‐4‐[4‐oxo‐2‐thioxo (oxo)‐1, 2, 3, 4‐tetrahydro‐3‐quinazolinyl] benzenes
GB2101990A (en) Isocarbostyril derivatives
NO127583B (en)
US4062891A (en) N-formyl-2,3,5,6-dibenzobicyclo[5.1.0]octan-4-methylamine
SU561513A3 (en) The method of obtaining piperazine derivatives or their salts
US4670461A (en) Formaldehyde derivatives of mitindomide
US4385179A (en) Process for preparing N-pyrrolyl-pyridazineamine derivatives
JPH07108909B2 (en) Novel 2 '"-substituted-4-deoxy-thiazolo [5,4-c] -rifamycin SV derivative
JPS5962593A (en) 3-substituted-5,7-dichlorotriazolopyrimidine derivative and its preparation
US3880854A (en) Selective dehalogenation
JPH05140168A (en) Indolocarbazole derivative and antitumor agent comprising the same as active ingredient
JPS5946511B2 (en) 1-(N-hydroxyalkylcarbamoyl)-5-fluorouracils and their production method
Baker et al. Synthesis of 6‐substituted pyrimidines by the wittig reaction. III. Via 2‐amino‐4‐hydroxy‐5‐phenylbutyl‐6‐pyrimidylmethyl triphenyl phosphonium bromide
JPS6023379A (en) Novel methylthioflavone compound substituted at 3-position and its preparation
JPS5970671A (en) Arylcarbostyryl derivative
US3436393A (en) 4'-methoxy-2,2,4-trialkyl-delta**3-isoflavan compounds
JPS59134744A (en) Tropolone derivative having antitumor action
USRE28865E (en) Selective dehalogenation